The study found significant intra-group CMT reductions in the DEX-I group, with a higher percentage reduction than the ...

Panelists discuss how emerging therapies—including TKIs, sustained-release implants, and gene therapy—may reduce treatment ...

In advanced dry disease, a key problem is failure of retinal pigment epithelium, often shortened to RPE. These cells help ...

Full-year 2025 preliminary1 U.S. net product revenues of $689 millionSYFOVRE® (pegcetacoplan injection) total injection demand grew 17% ...

Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, today announced that dosing is complete in ...

Switching from aflibercept to ranibizumab biosimilars maintains stability in nAMD treatment, offering a cost-effective ...

Clinical Trials in Cancer Cachexia, Inflammatory Bowel Disease and Retinal Disorders are Planned MONTVALE, N. J., Jan. 07, 2026 (GLOBE ...

Abstract: Inspired by the human retina, the development of neuromorphic vision systems featuring image perception, memory, and processing functions aims to address the limitations of traditional ...

Please provide your email address to receive an email when new articles are posted on . ORLANDO — In this video from the American Academy of Ophthalmology meeting, Stephen J. Kim, MD, discusses GLP-1 ...

Rodeo is an attending surgeon and vice chair of orthopedic research at the Hospital for Special Surgery and head team physician for the New York Giants. It’s hard to miss the buzz around regenerative ...